Navigating an executive leadership change? Use our eBook to facilitate a smooth transition. Download Now

Westicke Partners

Close

ICR Westwicke Blog

The ICR Westwicke Blog is designed to deliver information and insights into the ever-changing world of healthcare communications.

2022 Trends: How COVID Is Changing the Healthcare Landscape

Posted on January 12th, 2022. Posted by

Old woman with face mask getting vaccinated, coronavirus, covid-19 and vaccination concept.

The COVID-19 pandemic continues to drive significant changes to nearly every industry, from real estate to staffing to consumer goods — but it fundamentally changed how consumers view and access healthcare. As the U.S. continues to navigate the pandemic, alongside mixed economic data, supply chain challenges, and labor challenges, what lies ahead for the healthcare industry in 2022? Below, our experts offer their predictions.  

Continue Reading

10 Ways to Boost the Effectiveness of Your Biotech Investor Plan

Posted on December 21st, 2021. Posted by

African American boss with employees sitting at desk in boardroom, businesswoman with colleagues discussing business strategy or project together, using laptops, brainstorm or company meeting

Investors know that biotech and biopharma companies in the early development stages can be risky investments. So finding the right investors that believe the rewards will outweigh the risks requires strategy.

Continue Reading

10 Ways to Prep for the J.P. Morgan Healthcare Conference

Posted on December 6th, 2021. Posted by

10 Ways to Prep for the J.P. Morgan Healthcare Conference

Each year, the J.P. Morgan Healthcare Conference provides a critical opportunity to meet with analysts, investors, and other leaders in the healthcare industry. However, making the most of the conference takes preparation.

Continue Reading

What the COVID-19 Pandemic Taught Us About the Power of Words

Posted on November 18th, 2021. Posted by

doctor giving patient vaccine

As public health officials discuss whether to call subsequent COVID-19 vaccinations “boosters,” fearing it gives the impression that previous inoculations weren’t effective—some preferred “third dose” or “final dose”—chalk it up to yet another debate about words and nomenclature related to the worst global pandemic in a century.

Continue Reading

Tailor Your Investor Meetings to the Audience and Timeframe

Posted on November 10th, 2021. Posted by

You spend considerable time creating a professional investor presentation that tells a comprehensive story of your company. Yet aside from the analyst/investor due diligence meeting, few opportunities exist for you to deliver the entire presentation from start-to-finish. How, then, can you tailor your presentation to the time and opportunities at hand?

Continue Reading

The Current and Future State of Biotech Financing

Posted on November 1st, 2021. Posted by

In the face of a global pandemic, capital markets have (understandably) seen unprecedented behavior over the past two years. With vaccines, rapid testing, and medical research at center stage of every news outlet and publication, the biotech sector has been especially active. There have been major shifts in both buy- and sell-side activities, leaving many companies wondering how to best raise capital as the world finds its new normal. As young and emerging biotech companies look forward, there is growing concern about the current and future state of funding.

Continue Reading

4 Benefits of Conducting a Perception Audit

Posted on October 20th, 2021. Posted by

Full,Length,Portrait,Of,Business,Team,Stand,Near,The,Window

Do you know how the investment community views your company, including your products, leadership team, business strategy, and financial performance? Asking the tough questions and opening your company up to potential negative feedback can be a scary prospect, but it’s well worth it. By conducting a perception audit — an independent investigation into investor and analyst impressions of a company — your company can realize the following benefits. 

Continue Reading

Get Quoted: 5 Tips for Engaging with the Media

Posted on October 10th, 2021. Posted by

man making a statement to the media

Securing media coverage can be a fantastic opportunity to tell your company’s story, boost your reputation, and exhibit credible thought leadership in your industry. However, delivering articulate quotes can be challenging.

Continue Reading

Planning, Preparing and Positioning for Successful Investor Meetings

Posted on October 1st, 2021. Posted by

Investor meetings are essential for managing and expanding your shareholder base. They provide investors with clarity on a company’s story and can allow you to gauge potential investor concerns, but most importantly, they provide management the opportunity to control the story being told to investors.

The buy side often views a meeting with management as a critical component in their due diligence process. Even in the wake of increased scrutiny from SEC regulators regarding Reg FD, these meetings give the buy side more insight into a company story, recent developments, and potential headwinds.

Continue Reading

Challenges and Opportunities In Early-Stage Biotech Funding

Posted on September 23rd, 2021. Posted by

Challenges and Opportunities In Early-Stage Biotech Funding

The biotech market has been growing rapidly over the past two decades, and is expected to be worth nearly $2.5 trillion by 2028. Meanwhile, the pace of technological developments and innovation have reduced barriers to entry, leading to an influx of aspiring biotech startups eager to bring their products to market. But despite the increase in available capital, early-stage biotech companies are battling harder for their share of funding. In this article, we explore the challenges, strategies, and best practices in early-stage biotech funding.

Continue Reading

1 2 3 28

Clinical trial data disclosure can be tricky.

Download our checklist of 10 disclosure guidelines to minimize risk and maximize the impact of good news.

Download Now

Our Locations